-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE PHARMACEUTICALS APPOINTS DAVID SANDOVAL AS GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER

Reuters·02/10/2026 13:00:08

Please log in to view news